GOSS Insider Trading
Insider Ownership Percentage: 5.00%
Insider Buying (Last 12 Months): $249,240.00
Insider Selling (Last 12 Months): $1,259.28
Gossamer Bio Insider Trading History Chart
This chart shows the insider buying and selling history at Gossamer Bio by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Gossamer Bio Share Price & Price History
Current Price: $1.00
Price Change: ▼ Price Decrease of -0.1 (-9.09%)
As of 04/1/2025 04:03 PM ET
Gossamer Bio Insider Trading History
Gossamer Bio Institutional Trading History
Data available starting January 2016
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.
Read More on Gossamer Bio
Volume
1,560,963 shs
Average Volume
1,565,927 shs
Market Capitalization
$227.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.86
Who are the company insiders with the largest holdings of Gossamer Bio?